Home Cart Sign in  
Chemical Structure| 476-28-8 Chemical Structure| 476-28-8

Structure of Lycorine
CAS No.: 476-28-8

Chemical Structure| 476-28-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Lycorine, a natural product isolated and purified from the bulbus of Lycoris radiata (L. Herit.) Herb, has anti-cancer effect that dependent on STAT expression.

Synonyms: Galanthidine; NSC 401360; Belamarine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Lycorine

CAS No. :476-28-8
Formula : C16H17NO4
M.W : 287.31
SMILES Code : O[C@@H]1[C@@H](O)C=C(CC2)[C@@]3([H])N2CC4=C([C@@]31[H])C=C(OCO5)C5=C4
Synonyms :
Galanthidine; NSC 401360; Belamarine
MDL No. :MFCD00221746
InChI Key :XGVJWXAYKUHDOO-DANNLKNASA-N
Pubchem ID :72378

Safety of Lycorine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse CD4+ T cells 200 nM 72 h Inhibited T-cell proliferation PMC10238213
SGC-7901 cells 10, 20, 40 μM 48 h LH significantly inhibited cell growth, with an IC50 of approximately 20 μM PMC7602321
Mouse splenocytes 200 nM 15 min Inhibited ERK1/2 phosphorylation PMC10238213
U251 0, 10 μM 7 days Lycorine inhibited U251 cell colony formation in a concentration-dependent manner. PMC6050662
U251 0, 10 μM 5 to 7 h Lycorine significantly inhibited U251 cell migration in a dose-dependent manner. PMC6050662
MKN-45 cells 10, 20, 40 μM 48 h LH significantly inhibited cell growth, with an IC50 of approximately 20 μM PMC7602321
HCA2 fibroblasts 1 μM 14 days Suppressed IR-induced cellular senescence, reduced β-gal positive cells PMC7884038
HepG2 cells 10 µM 1 h Identified Lycorine as a SCAP-binding compound via CETSA screening PMC8354609
Human PBMCs 200 nM 72 h Inhibited T-cell proliferation and cytokine production PMC10238213
HL-7702 cells 10, 20 µM 12 h Inhibited SREBFs activity, reduced cellular lipid levels, without inducing ER stress or NR1H3 activity PMC8354609
MM.1S 2.5, 5, 10 μM 24 h Lycorine significantly reduced the viability of MM cells but did not significantly affect B-cells at the same concentrations. PMC5135444
H929 2.5, 5, 10 μM 24 h Lycorine significantly reduced the viability of MM cells but did not significantly affect B-cells at the same concentrations. PMC5135444
ARH-77 2.5, 5, 10 μM 24 h Lycorine significantly reduced the viability of MM cells but did not significantly affect B-cells at the same concentrations. PMC5135444
ARP-1 2.5, 5, 10 μM 24 h Lycorine significantly reduced the viability of MM cells but did not significantly affect B-cells at the same concentrations. PMC5135444
ANBL6 2.5, 5, 10 μM 24 h Lycorine significantly reduced the viability of MM cells but did not significantly affect B-cells at the same concentrations. PMC5135444
U251 0, 1, 5, 10, 25, 50 μM 48 h Lycorine inhibited U251 cell proliferation in a dose-dependent manner with an IC50 of approximately 10 μM. PMC6050662
A549 cells 0–10μM 72 h Lycorine significantly increased the protein levels of SAV1 and p-MST1 in A549 cells, indicating its activation of the tumor-suppressive Hippo pathway by inhibiting the ubiquitination degradation of SAV1. PMC7242319
SPC-A-1 cells 0–10μM 72 h Lycorine significantly increased the protein levels of SAV1 and p-MST1 in SPC-A-1 cells, indicating its activation of the tumor-suppressive Hippo pathway by inhibiting the ubiquitination degradation of SAV1. PMC7242319
BMSCs cells 800 µg/mL 24 h To evaluate the cytotoxicity of GNS@MSNs-FA on BMSCs cells, results showed that even at high concentrations, GNS@MSNs-FA did not exhibit significant cytotoxicity. PMC8314456
MNNG/HOS cells 0.5 µg/mL 24 h To evaluate the cytotoxicity of Lycorine on MNNG/HOS cells, results showed that Lycorine significantly reduced cell viability. PMC8314456

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice High-fat diet-induced obese mice Gastric irrigation 15 or 30 mg/kg Once daily for 6 weeks Ameliorated high-fat diet-induced obesity, hyperlipidemia, hepatic steatosis, and insulin resistance PMC8354609
Mice Cardiac transplant model Intraperitoneal injection 5 mg/kg Once or twice daily, continued until the heart graft stopped beating Prolonged cardiac allograft survival and inhibited T-cell infiltration and function PMC10238213
NOD/SCID mice Multiple myeloma xenograft model Intraperitoneal injection 5 mg/kg Every 4 days, until day 26 Lycorine efficiently inhibited tumor growth, significantly reduced tumor volume, and did not cause significant toxicity. PMC5135444
Nude mice U251-luc intracranial orthotopic transplantation model Intraperitoneal injection 10 mg/kg, 20 mg/kg Once daily for 40 days Lycorine significantly inhibited tumor growth in the U251-luc intracranial orthotopic transplantation model in a dose-dependent manner. PMC6050662
Nude mice Lung cancer xenograft model Intraperitoneal injection 10 mg/kg Once daily for 28 days Lycorine significantly inhibited tumor growth in lung cancer xenograft mice, reducing tumor volume and weight, indicating its suppression of tumor growth by increasing SAV1 levels. PMC7242319
Nude mice MNNG/HOS tumor model Intraperitoneal injection 10 mg/kg Every three days for 12 days To evaluate the in vivo antitumor effect of GNS@MSNs-FA/Ly combined with NIR irradiation on MNNG/HOS tumors, results showed that the combined treatment significantly inhibited tumor growth. PMC8314456
Nude mice Subcutaneous tumor xenograft model Subcutaneous injection 30 mg/kg Once daily for 16 days LH significantly inhibited tumor growth, reducing tumor volume and weight PMC7602321

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.48mL

0.70mL

0.35mL

17.40mL

3.48mL

1.74mL

34.81mL

6.96mL

3.48mL

References

 

Historical Records